Formula milk trials are not reliable, warn experts

Recent trials lack scientific rigour; substantial change needed to protect participants from harm and protect consumers from misleading information

Formula milk trials have a high risk of bias, authors almost always report favourable conclusions, transparency is lacking, and findings are selectively reported, finds a review of evidence from recently published trials in The BMJ today.

The researchers say their findings “support the need for a substantial change in the conduct and reporting of formula trials to adequately protect participants from harm and protect consumers from misleading information.”

Formula milk is consumed by most European and North American infants, and new formula products need to be tested in clinical trials. But concerns have been raised that formula trials are biased and could undermine breastfeeding.

To explore this further, an international team of researchers set out to evaluate the conduct and reporting of formula milk trials. They were specifically interested in understanding the risk of bias in published formula trials and if trial procedures could cause harm by undermining breastfeeding of participants.

They carried out a detailed analysis of 125 trials published since 2015 that compared at least two formula milk products in a total of 23,757 children less than three years of age. 

The trials were mainly carried out in Europe (42%), Asia (28%), or North America (18%) and the most common measures were weight gain (36%), intestinal health (26%), nutrient absorption (10%), behaviour (6%), and allergy (6%).

The researchers found that only 17 (14%) of these trials were conducted independently of formula companies, 26 (21%) were prospectively registered with a clear aim and main (primary) outcome, and 11 (9%) had a publicly available protocol.

Most (80%) of trials had a high risk of bias for their primary outcome, usually because of inappropriate exclusions of participants from the analysis, and selective reporting (when results are not fully or accurately reported, to suppress negative or undesirable findings).

Favourable conclusions were reported for more than 90% of trials.

This is a comprehensive evaluation of the conduct and reporting of formula trials, but the researchers acknowledge that because the results of many formula trials are not in the public domain, their findings cannot fully represent all trials conducted.

Nevertheless, they say their study suggests that formula trials are not reliable and might not adequately protect participants in the trials.

“The formula industry is closely involved in formula trials, findings are almost always reported as favourable, and little transparency exists about the aims of the trial or reporting of results,” they write. “Our findings support the need for a substantial change in the conduct and reporting of formula trials to adequately protect participants from harm and protect consumers from misleading information.”

Tags : #FormulaMilk #FormulaMilkIndustry #FormulaMilkTrials #TheBMJ

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024